Integration of TB and ART services fails to improve TB treatment outcomes: Comparison of ART/TB primary healthcare services in Cape Town, South Africa

South African Medical Journal

Volumn 104, Issue 3, 2014, Pages 204-209

  Kaplan, R ^a   Caldwell, J ^b   Bekker, L G ^a   Jennings, K ^b   Lombard, C ^c,d   Enarson, D A ^d,e   Wood, R ^a   Beyers, N ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b City of Cape Town   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

^e INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

Antiretroviral therapy; HIV; Treatment outcomes; Tuberculosis

Indexed keywords

CLOTRIMAZOLE; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FEMALE; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; COMMUNITY HEALTH SERVICES; FEMALE; HIV INFECTIONS; HUMANS; MALE; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84894813183     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.7696     Document Type: Article

References (20)

1. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: Impact on treatment outcomes and implications for tuberculosis control. AIDS 2006;20(12):1605-1612. [http://dx.doi.org/10.1097/01.aids.0000238406.93249.cd]
2. Wood R, Lawn SD, Caldwell J, Kaplan R, Middelkoop K, Bekker LG. Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLoS One 2011;6:e25098. [http://dx.doi.org/10.1371/journal.pone.0025098]
3. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med 2003;163(9):1009-1021. [http://dx.doi.org/10.1001/archinte.163.9.1009]
4. Straetemans M, Bierrenbach AL, Nagelkerke N, Glaziou P, van der Werf MJ. The effect of tuberculosis on mortality in HIV positive people: A meta-analysis. PLoS One 2010;5:e15241. [http://dx.doi.org/10.1371/journal.pone.0015241]
5. Kaplan R, Bekker LG, Caldwell J, et al. HIV Prevalence, CD4 Count Distribution and Case Fatality for TB Patients Treated in Primary Health Care Facilities in Cape Town. Abstract #306. 2nd South African TB Conference; 1-4 June 2010; Durban, SA.
6. National Department of Health. Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents, 2010. Pretoria: NDoH, 2010. http://www.sahivsoc.org/upload/documents/Clinical_Guidelines_for_the_Management_of_HIV_AIDS_in_Adults_Adolescents_2010.pdf (accessed 23 January 2014).
7. Lawn SD, Campbell L, Kaplan R, et al. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa. J Acquir Immune Defic Syndr 2011;57(2):136-140. [http://dx.doi.org/10.1097/QAI.0b013e3182199ee9]
8. Lawn SD, Campbell L, Kaplan R, Little F, Morrow C, Wood R. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township. BMC Infect Dis 2011;11:258. [http://dx.doi.org/10.1186/1471-2334-11-258]
9. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011;365(16):1471-1481. [http://dx.doi.org/10.1056/NEJMoa1013911]
10. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011;365(16):1482-1491. [http://dx.doi.org/10.1056/NEJMoa1013607]
11. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosistreatment. N Engl J Med 2011;365(16):1492-1501. [http://dx.doi.org/10.1056/NEJMoa1014181]
12. South African National AIDS Council, National Department of Health. National Strategic Plan on HIV, STIs and TB 2012-2016. Pretoria: NDoH, 2011. http://www.info.gov.za/view/DownloadFileAction?id=155622 (accessed 23 January 2014).
13. National Department of Health. National Tuberculosis Management Guidelines 2009. Pretoria: NDoH, 2009. http://familymedicine.ukzn.ac.za/Libraries/Guidelines_Protocols/TB_Guidelines_2009.sflb.ashx(accessed 23 January 2014).
14. National Department of Health. National Antiretroviral Treatment Guidelines. 1st ed. Pretoria: NDoH, 2004. http://southafrica.usembassy.gov/media/2004-doh-art-guidelines.pdf (accessed 23 January 2014).
15. World Health Organization. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva: WHO, 2010. http://www.who.int/tb/publications/2010/9789241547833/en/ (accessed 23 January 2014).
16. Brown C, Kerschberger B, Boulle A, et al. TB and HIV Service Integration within a South African Primary Health Care Setting Reduces the Time to ART Initiation without Negatively Impacting TB Outcomes. Abstract #890.18th Conference on Retroviruses and Opportunistic Infections; 27 February-2 March 2011; Boston, USA.
17. Hermans SM, Castelnuovo B, Katabira C, et al. Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda. J Acquir Immune Defic Syndr 2012;60(2):e29-e35. [http://dx.doi.org/10.1097/QAI.0b013e318251aeb4]
18. Shaffer DN, Obiero ET, Bett JB, et al. Successes and challenges in an integrated tuberculosis/HIV clinic in a rural, resource-limited setting: Experiences from Kericho, Kenya. AIDS Res Treat 2012;2012:238012. [http://dx.doi.org/10.1155/2012/238012]
19. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation ofantiretrovirals during antituberculosis therapy in Africa. PLoS One 2011;6(5):e19484. [http://dx.doi.org/10.1371/journal.pone.0019484]
20. Nglazi MD, Kaplan R, Caldwell J, et al. Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. S Afr Med J 2012;102(12):936-939. [http://dx.doi.org/10.7196/SAMJ.6024]